X-SOLVE

INCI Name:

Ethyl Ximenynate, Lecithin, Caprylic/Capric triglyceride, Glycerin

Description

Active ingredient composed of Ethyl Ximeninate and encapsulated in lecithin vesicles with a patented encapsulation technology that allow a better delivery of the ingredient. Thanks to its vasoactive capabilities, it improves blood flow in superficial vessels, promoting the microcirculation in disordered skins (cellulitis, local fat accumulation, heavy legs). It also fosters actin production in fibroblasts, suggesting a role in dermal remodelling, and prevents local inflammations at prostaglandin level by preventing the formation of arachidonic acid.

Origin

Obtained by the encapsulation under high pressure homogenization of Ethyl Ximenynate into lipophilic vesicles constituted by Lecithin.

Applications

  • Recommended for body care and scalp products.

Mechanism of Action

It decreases the metabolism of Arachidonic Acid preventing the cause of edema and the releasing of COX 

Key features

  • Arachidonic acid and skin microcirculation modulator

Usage Dosage

1-3%

Form

Gel

Efficacy tests

In vitro:

  • Actina gene expression profile evaluation
  • Nitric oxide production

In vivo:

  • Study on the vasoactive effect

Preservation

Certifications

Applications

  • Microcirculation

Confidential contents

  • Technical sheet
  • Safety sheet
  • Formulary
    (distributors reserved)
  • Brochure
    (distributors reserved)
  • General statements
    (distributors reserved)
  • Tox Tests
    (distributors reserved)
  • Efficacy Tests
    (distributors reserved)

To view confidential content you must login:

Sinerga
Loading...